159 related articles for article (PubMed ID: 16705742)
1. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy.
Johansson B; Pourian MR; Chuan YC; Byman I; Bergh A; Pang ST; Norstedt G; Bergman T; Pousette A
Prostate; 2006 Sep; 66(12):1235-44. PubMed ID: 16705742
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
[TBL] [Abstract][Full Text] [Related]
3. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.
Pang ST; Weng WH; Flores-Morales A; Johansson B; Pourian MR; Nilsson P; Pousette A; Larsson C; Norstedt G
Prostate; 2006 Feb; 66(2):157-72. PubMed ID: 16173030
[TBL] [Abstract][Full Text] [Related]
6. Estrogens affect endothelin-1 mRNA expression in LNCaP human prostate carcinoma cells.
Grande M; Carlström K; Stege R; Pousette A; Faxén M
Eur Urol; 2002 May; 41(5):568-72; discussion 573-4. PubMed ID: 12074801
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
[TBL] [Abstract][Full Text] [Related]
9. Androgens induce CD-9 in human prostate tissue.
Chuan Y; Pang ST; Bergh A; Norstedt G; Pousette A
Int J Androl; 2005 Oct; 28(5):291-6. PubMed ID: 16128989
[TBL] [Abstract][Full Text] [Related]
10. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2009 Dec; 22(6):1451-8. PubMed ID: 19885599
[TBL] [Abstract][Full Text] [Related]
11. Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
Leiblich A; Cross SS; Catto JW; Pesce G; Hamdy FC; Rehman I
Prostate; 2007 Dec; 67(16):1761-9. PubMed ID: 17929277
[TBL] [Abstract][Full Text] [Related]
12. Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells.
Hara T; Kouno J; Nakamura K; Kusaka M; Yamaoka M
Prostate; 2005 Nov; 65(3):268-75. PubMed ID: 16015592
[TBL] [Abstract][Full Text] [Related]
13. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
Rehman I; Cross SS; Azzouzi AR; Catto JW; Deloulme JC; Larre S; Champigneuille J; Fromont G; Cussenot O; Hamdy FC
Br J Cancer; 2004 Aug; 91(4):739-44. PubMed ID: 15280928
[TBL] [Abstract][Full Text] [Related]
14. Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer.
Shen J; Zhau HE; Hursting SD; Chung LW
Mol Carcinog; 1998 Sep; 23(1):13-9. PubMed ID: 9766433
[TBL] [Abstract][Full Text] [Related]
15. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
18. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
19. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
20. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.
van Steenbrugge GJ; van Uffelen CJ; Bolt J; Schröder FH
J Steroid Biochem Mol Biol; 1991; 40(1-3):207-14. PubMed ID: 1958522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
